GlaxoSmithKline CFO Dingemans to retire in 2019

Simon Dingemans will retire as chief financial officer of GlaxoSmithKline and step down from the board in May 2019, the pharmaceuticals giant said on Wednesday.

Glaxo said it will now begin a "thorough global search" both internally and externally to identify a successor to Dingemans, who joined the group in 2011.

Chief executive officer Emma Walmsley said: "Since joining GSK, Simon has played a very significant role in shaping the company. He has taken a consistent and sustained approach to support investment and improve operational efficiencies in all three of our global businesses.

"I am particularly grateful for his support and partnership since I took on the role of CEO and his counsel to me as we defined our new strategy. I want to take this opportunity to thank him for all he's done for GSK."

Dingemans said: "It has been a privilege to be part of GSK and to have had the opportunity as CFO to lead many key initiatives to drive the company forward and make it fitter for the future. With the new strategy set, we have established strong foundations to deliver improved business and financial performance and I believe now is the right time for me to take this decision."